Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Eye Drops & Ophthalmic Recalls

Recalls of ophthalmic solutions and eye drops - a category hit by widely reported contamination recalls.

673 recalls in this category, newest first.

Class II · Moderate risk

Timolol-Latanoprost PF Solution

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Terminated Chemical / undeclared ImprimisRx CA, Inc., dba ImprimisRx D-1132-2017
Class II · Moderate risk

Latanoprost PF Solution

Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Terminated Chemical / undeclared ImprimisRx CA, Inc., dba ImprimisRx D-1131-2017
Class II · Moderate risk

Blephamide

Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.

Terminated Impurity / degradation Allergan Sales, LLC D-0929-2017
Class II · Moderate risk

Vit C/Gsh 1.25%-1.25% Ophth

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0759-2017
Class II · Moderate risk

Atropine Sulfate 0.5% Ophth

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0712-2017
Class II · Moderate risk

Atropine Sulfate 0.01% Ophth

Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.

Terminated Sterility / contamination Key Pharmacy and Compounding Center D-0711-2017
Class II · Moderate risk

Phenylephrine 2.5%

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Isomeric Pharmacy Solution, LLC D-0687-2017
Class II · Moderate risk

Refresh Tears

Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.

Terminated Labeling / mix-up Cell Distributors D-0865-2017
Class II · Moderate risk

Sato Clear

Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Terminated Sterility / contamination Sato Pharmaceutical Inc. NDC 49873-044-01 D-0855-2017
Class II · Moderate risk

Optic Splash

Lack of Assurance of Sterility: Firm failed to establish an adequate system for monitoring environmental conditions in aseptic processing areas.

Terminated Sterility / contamination Sato Pharmaceutical Inc. NDC 49873-501-01 D-0854-2017
Class III · Low risk

Levofloxacin Ophthalmic Solution

Failed Impurities/ Degradation Specifications: OOS for related compound (levofloxacin n-oxide) at the 18 month stability time point.

Terminated Impurity / degradation Actavis Inc NDC 50383-283-05 D-0514-2017